Abstract:Overdose of acetaminophen (APAP), the most widely used analgesic, results in acute liver failure. We have investigated the role of a post‐translational modification of proteins called O‐GlcNAcylation in pathogenesis of APAP‐induced liver injury, where a single β‐D‐N‐acetylglucosamine (O‐GlcNAc) moiety is added to proteins by an enzyme called O‐GlcNAc transferase (OGT) and removed by an enzyme called O‐GlcNAcase (OGA). Male C57BL/6J mice were treated with 300 mg/kg APAP followed by Thiamet‐G (TMG, 400 mg/kg) a specific inhibitor of OGA that induces O‐GlcNAcylation, 1.5 hr after APAP administration. Progression of liver injury was studied over a time course of 0 to 24 hr. TMG treatment resulted in significant increase in hepatic O‐GlcNAc. The mice treated with 400 mg/kg TMG exhibited significantly higher APAP‐induced liver injury as indicated by increase in serum transaminase levels and histopathological analysis, as well as a prolonged JNK activation. Treatment with TMG did not affect hepatic CYP2E1 levels, APAP protein adduct formation, APAP induced mitochondrial damage, hepatic glutathione (GSH), or depletion of GSH after APAP treatment. C57BL/6J mice were also treated with 50 mg/kg TMG every other day for 15 days followed by 300 mg/kg APAP and sacrificed at 24 hr. Mice treated with 50 mg/kg TMG showed a similar increase in APAP‐induced liver injury. Next we used hepatocyte specific OGT knockout mice (OGT KO), which have decreased O‐GlcNAcylation to study APAP toxicity. OGT KO and WT control mice were treated with 300 mg/kg and sacrificed on a timecourse from 0–24 hr. OGT KO mice showed dramatic decrease in liver injury as compared to WT mice. APAP protein adducts was significantly decreased in OGT KO mice when compared to WT control mice. There was no difference CYP2E1 activity showing that OGT KO did not alter cytochrome P450 levels and alter APAP metabolism. Hepatic GSH depletion was equal in OGT KO and WT mice but GSH was rapidly replenished by 6hr after APAP treatment in OGT KO mice, while WT mice did not fully replenish until 24hr post APAP. Taken together, these data indicate that induction in cellular O‐GlcNAcylation exacerbates and decrease in O‐GlcNAcylation protects from APAP induced liver injury. These studies have identified a novel mechanism of pathogenesis of acute liver injury induced by APAP and highlighted a novel therapeutic target for acute liver failure. Support or Funding Information R01DK098414

Acetaminophen-induced Reduction in Glutathione-S-transferase A1 in Hepatocytes: A Role for Hepatic Nuclear Factor 1α and Its Response Element.

Acetaminophen-induced hepatocyte injury: C2-ceramide and oltipraz intervention, hepatocyte nuclear factor 1 and glutathione S-transferase A1 changes.

Effects of C2-Ceramide and Oltipraz on Hepatocyte Nuclear Factor-1 and Glutathione S-Transferase A1 in Acetaminophen-Mediated Acute Mice Liver Injury.

Expression of Glutathione S-transferase A1, a Phase II Drug-Metabolizing Enzyme in Acute Hepatic Injury on Mice

Role of Hepatic O‐GlcNAcylation on Acetaminophen‐Induced Liver Injury

JNK Signaling Pathway Mediates Acetaminophen-Induced Hepatotoxicity Accompanied by Changes of Glutathione S-Transferase A1 Content and Expression

Glutaredoxin-1 Alleviates Acetaminophen-Induced Liver Injury by Decreasing Its Toxic Metabolites

GLT25D2 is Critical for Inflammatory Immune Response to Promote Acetaminophen-Induced Hepatotoxicity by Autophagy Pathway

GADD45α Alleviates Acetaminophen-Induced Hepatotoxicity by Promoting AMPK Activation

Apigenin Attenuates Acetaminophen-Induced Hepatotoxicity by Activating AMP-Activated Protein Kinase/Carnitine Palmitoyltransferase I Pathway

Glutathione S-transferase A1 Suppresses Tumor Progression and Indicates Better Prognosis of Human Primary Hepatocellular Carcinoma

Glutathione S-transferase A1 (GSTA1) release, an early indicator of acute hepatic injury in mice

Acetaminophen-induced Cytotoxicity on Human Normal Liver L-02 Cells and the Protection of Antioxidants.

EGR1 is Crucial for the Chlorogenic Acid–provided Promotion on Liver Regeneration and Repair after APAP-induced Liver Injury

Egr1 Confers Protection Against Acetaminophen‑induced Hepatotoxicity Via Transcriptional Upregulating of Acaa2.

Glycyrrhetinic Acid Prevents Acetaminophen-Induced Acute Liver Injury Via the Inhibition of CYP2E1 Expression and HMGB1-TLR4 Signal Activation in Mice.

Effect of trifluoperazine on toxicity, HIF-1α induction and hepatocyte regeneration in acetaminophen toxicity in mice

Hepatic Hypoxia-Inducible Factors Inhibit PPARα Expression to Exacerbate Acetaminophen Induced Oxidative Stress and Hepatotoxicity

Acetaminophen Responsive Mir-19B Modulates SIRT1/Nrf2 Signaling Pathway in Drug-Induced Hepatotoxicity

GAS1 Promotes Ferroptosis of Liver Cells in Acetaminophen-Induced Acute Liver Failure.

Histone Methyltransferase G9a Protects Against Acute Liver Injury Through GSTP1